Barbara Doran, CIO at BD8 Capital Partners, joined CNBC on June 20 to discuss how she sees markets holding steady after a strong rebound. Doran observed the market’s current action in futures and noted that despite an earlier slight downturn, the market has continued to trend higher throughout the morning without any specific news or clear catalyst. She attributed this to the broader market direction, which has seen a V-shaped recovery since the lows of April, according to her, supported by generally solid economic data. Doran then referenced the then-recent Fed policy meeting and announcements. While the Fed maintained interest rates as expected, they did lower their GDP forecast and, for the second time this year, raised their inflation forecast. She explained that the market is currently on hold, awaiting the flow-through impact of tariffs.
There’s a strong expectation of pull-through forward buying needing to be worked off, which should eventually manifest in the economic numbers. However, investors currently believe that any tariff impact has largely been discounted by the market, given the recovery since the intolerably high tariff announcements on April 2. Doran pointed out that after the big V-shaped recovery, the market is trading at over 22x earnings, which is historically pretty high and indicates limited immediate upside. She noted that the ongoing tax package discussion, but suggested it’s primarily an extension of tax cuts, not a major new catalyst. Doran concluded that there’s not much upside action expected in the near term, but equally, not much downside until more definitive data emerges to clarify the underlying risks.
That being acknowledged, we’re here with a list of the 10 best performing NYSE stocks to buy now.
A professional stock market trader in a suit in front of a computer, monitoring movements of different stocks.
Our Methodology
We sifted through the Finviz stock screener to compile a list of the best-performing stocks that are listed on the NYSE and have a year-to-date performance exceeding 75% as of June 23. We then selected 10 stocks that were the most popular among elite hedge funds and that analysts were bullish on. The stocks are ranked in ascending order of the number of hedge funds that have stakes in them, as of Q1 2025.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
10 Best Performing NYSE Stocks to Buy Now
10. Claritev Corporation (NYSE:CTEV)
Year-to-Date Performance as of June 23: 180.72%
Number of Hedge Fund Holders: 13
Claritev Corporation (NYSE:CTEV) is one of the best-performing NYSE stocks to buy now. On June 17, Claritev Corporation announced its membership in the Coalition for Health AI/CHAI. CHAI is an industry-led coalition dedicated to establishing best practices and frameworks for innovation, safety, and security in health AI. Claritev aims to enhance healthcare affordability, transparency, and fairness.
The collaboration will help develop and deploy responsible AI practices within the healthcare ecosystem. Claritev intends to contribute its expertise in healthcare data integration and analytics to CHAI’s initiatives, particularly in areas such as transparency, fairness, safety, and privacy in AI.
Claritev provides solutions and services powered by over 40 years of claims processing data, using technology and AI to offer insights that drive affordability and price transparency. Claritev serves 700+ healthcare payors, 100,000+ employers, 60 million consumers, and 1.4 million contracted providers. The coalition comprises leaders and experts from health systems, startups, government, and patient advocacy groups.
Claritev Corporation (NYSE:CTEV) provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the US.
9. D-Wave Quantum Inc. (NYSE:QBTS)
Year-to-Date Performance as of June 23: 77.86%
Number of Hedge Fund Holders: 13
D-Wave Quantum Inc. (NYSE:QBTS) is one of the best-performing NYSE stocks to buy now. On June 17, D-Wave Quantum announced the signing of a Memorandum of Understanding/MOU with Yonsei University and Incheon Metropolitan City in South Korea. The agreement aims to accelerate the adoption of quantum computing in the region to support South Korea’s ambition to become a global quantum technology hub.
The MOU outlines a collaborative effort focused on mutual research, talent development, and the exploration of quantum computing. A key aspect of the collaboration is to facilitate the acquisition of a D-Wave Advantage2 quantum system at the Yonsei University International Campus in Songdo, Yeonsu-gu, Incheon. The Advantage2 system is D-Wave’s sixth-generation annealing quantum computer and features over 4,400 qubits, 20-way connectivity, and improvements in energy scale and noise reduction.
D-Wave is recognized as the world’s first commercial supplier of quantum computers. The company’s quantum systems are available on-premises or via the cloud with 99.9% availability and uptime, and have processed over 200 million problems to date. More than 100 organizations currently utilize D-Wave’s technology. Yonsei University also constructed its Quantum Convergence Research Center in February 2025 and established a Yonsei Quantum Complex for quantum education and research.
D-Wave Quantum Inc. (NYSE:QBTS) develops and delivers quantum computing systems, software, and services worldwide.
